Wentao Innovative Drug Research (Beijing) Co.
Latest round
- Series A
Last raised
- Jul 2022
Total raised
- $1.5M
Investors
- 1
About Wentao Innovative Drug Research (Beijing) Co.
, Ltd is a pharmaceutical company engaged in R & D and production of new drugs. The company has a new drug research and development center, drug production base, API production base, and drug sales agent cooperation. The company can realize dosage form improvement for children's drugs, geriatric drugs, and chronic disease drugs, and fixed-point release of compound formulations through microsphere technology. The company has several new drugs under clinical BE validation. It can achieve a production capacity of more than 200,000 preparations per day.
Who invested in Wentao Innovative Drug Research (Beijing) Co.
1 investor across 1 round
See all investors in Wentao Innovative Drug Research (Beijing) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 28, 2022
Amount
$1.5M
Investors
Questions about Wentao Innovative Drug Research (Beijing) Co.
Who invested in Wentao Innovative Drug Research (Beijing) Co.?
Wentao Innovative Drug Research (Beijing) Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wentao Innovative Drug Research (Beijing) Co. raised?
Wentao Innovative Drug Research (Beijing) Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Wentao Innovative Drug Research (Beijing) Co. last raise money?
Wentao Innovative Drug Research (Beijing) Co.'s most recent round on record is a Series A, in Jul 2022.
What does Wentao Innovative Drug Research (Beijing) Co. do?
, Ltd is a pharmaceutical company engaged in R & D and production of new drugs.
Where is Wentao Innovative Drug Research (Beijing) Co. headquartered?
Wentao Innovative Drug Research (Beijing) Co. is headquartered in Beijing, China.
Which VCs invest in companies like Wentao Innovative Drug Research (Beijing) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Wentao Innovative Drug Research (Beijing) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Wentao Innovative Drug Research (Beijing) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.